Skip to main content
Signal8

Kennedy Patrick

SEC insider (Form 3/4/5 filer). CIK 0002013944. Director at Jazz Pharmaceuticals plc (JAZZ). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in DUBLIN 4.

Companies Kennedy Patrick has filed insider reports for

  • Jazz Pharmaceuticals plc (JAZZ): Director
Kennedy Patrick profile photo

Kennedy Patrick

CIK: 0002013944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jazz Pharmaceuticals plc logo
JAZZ

Jazz Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 31, 2026
    Tax Payment
    Direct
    15 shares at avg. $244.06$4K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 31, 2026
    Tax Payment
    Direct
    1.8K shares at avg. $241.39$444K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 5, 2026
    Award
    Direct
    1.6K shares-
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 8, 2025
    Tax Payment
    Direct
    2K shares at avg. $111.25$218K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 7, 2025
    Award
    Direct
    3.5K shares-

1-5 of 5